ERBB2 and breast carcinoma: To investigate whether pathways driving Mcl-1 expression are specifically active in HER2 overexpressing cancers, compared to other breast cancers, we analyzed the expression of 20 pro- and anti-apoptotic Bcl-2 family members from published gene-expression profiles of breast cancer patients.